Tetra Bio-Pharma Announces Drug Candidate as Potential Therapy for Managing Cytokine Release Syndrome $tbp ⁦@TetraBioPharma⁩ $cgc $apha $nvs $pfe #Covid_19 @JimWatsonOttawa⁩ ⁦@fordnation⁩ ⁦@US_FDA⁩ ⁦@realDonaldTrump⁩ ⁦#ottawa https://t.co/xkOKqrPECG